ATAI Life Sciences NV (ATAI)
2.18
+0.06
(+2.83%)
USD |
NASDAQ |
May 03, 10:07
ATAI Life Sciences Shareholders Equity (Quarterly): 242.96M for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 242.96M |
| September 30, 2023 | 266.28M |
| June 30, 2023 | 212.55M |
| March 31, 2023 | 236.82M |
| December 31, 2022 | 260.74M |
| September 30, 2022 | 289.40M |
| June 30, 2022 | 311.68M |
| Date | Value |
|---|---|
| March 31, 2022 | 346.01M |
| December 31, 2021 | 376.91M |
| September 30, 2021 | 453.19M |
| June 30, 2021 | 474.85M |
| March 31, 2021 | 111.39M |
| December 31, 2020 | 90.82M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
90.82M
Minimum
Dec 2020
474.85M
Maximum
Jun 2021
282.58M
Average
266.28M
Median
Sep 2023
Shareholders Equity (Quarterly) Benchmarks
| Affimed NV | 63.90M |
| InflaRx NV | 113.39M |
| MorphoSys AG | 54.22M |
| BioNTech SE | 22.38B |
| Immatics NV | 248.81M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 293.48M |
| Total Liabilities (Quarterly) | 49.16M |
| Debt to Equity Ratio | 0.0736 |
| Current Ratio | 9.224 |
| Net Debt Paydown Yield | -0.25% |